News for 'National Institute for Health Research'

SC asks Delhi police to not issue licence for sale, storage of firecrackers

SC asks Delhi police to not issue licence for sale, storage of firecrackers

Rediff.com14 Sep 2023

The Supreme Court on Thursday asked the Delhi police not to issue temporary licences for sale and storage of any kind of firecrackers, saying when the city government has banned all firecrackers no distinction can be made on the basis of whether it is green or not.

At ASEAN, Modi presents 12-point proposal to bolster cooperation

At ASEAN, Modi presents 12-point proposal to bolster cooperation

Rediff.com7 Sep 2023

Modi attended the 20th ASEAN-India Summit in Jakarta. Secretary-General of ASEAN Dr Kao Kim Hourn also attended the summit.

British Indian doc's call for Delhi to suspend Covishield use finds support

British Indian doc's call for Delhi to suspend Covishield use finds support

Rediff.com6 Feb 2023

A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered in India as Covishield, over feared serious side effects such as heart attack and stroke.

Stringent curbs set in but Delhi's air quality still 'severe'

Stringent curbs set in but Delhi's air quality still 'severe'

Rediff.com6 Nov 2023

The poisonous haze has been causing significant problems for people with existing respiratory issues, according to doctors.

Homeopathic cure for cancer catches US fancy

Homeopathic cure for cancer catches US fancy

Rediff.com23 Jan 2004

American's National Institute of Health will study a cancer care protocol developed by a Kolkata-based father-son homeopath duo.

'India examining possibilities': Govt on Pfizer Covid vaccine

'India examining possibilities': Govt on Pfizer Covid vaccine

Rediff.com17 Nov 2020

The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.

'Unprecedented vaccine trial in India'

'Unprecedented vaccine trial in India'

Rediff.com23 Dec 2020

Bharat Biotech recruited 13,000 participants for the Phase-3 clinical trial of Covaxin. This is one of the largest efficacy trials held in the country.

Govt seals deal for 30cr vaccines from Hyderabad firm

Govt seals deal for 30cr vaccines from Hyderabad firm

Rediff.com3 Jun 2021

The COVID-19 vaccine of Biological-E is currently undergoing phase-3 clinical trial after showing promising results in phase 1 and 2 trials.

Healthcare workers, those above 65 yrs to be given vaccine first: Govt

Healthcare workers, those above 65 yrs to be given vaccine first: Govt

Rediff.com19 Nov 2020

Health Minister Harsh Vardhan said the COVID-19 vaccine will be available in the next few months and it is estimated that by July-August 400-500 million doses will be made available for 25-30 crore people.

Using a mouthwash can increase risk of diabetes?

Using a mouthwash can increase risk of diabetes?

Rediff.com2 Dec 2017

Nearly all popular mouthwash solutions include ingredients that kill bacteria -- both the good and bad.

Insecurity in love takes a toll on your immunity

Insecurity in love takes a toll on your immunity

Rediff.com15 Feb 2007

Experiments showed that the women's natural killer immune system cells were less lethal compared with those from other study participants.

12 cases of swine flu detected in Pune

12 cases of swine flu detected in Pune

Rediff.com14 Mar 2012

Detection of about 12 Swine flu cases in the last fortnight has put the health authorities In Pune on an alert, as two patients are reported to be in a critical condition.

Special group to tackle SARS

Special group to tackle SARS

Rediff.com24 Apr 2003

The doctors treating SARS suspects or patients will use the Defence Research Development Organisation made Nuclear-Biological-Chemical weapon masks.

Dating? Do Your Political Views Matter?

Dating? Do Your Political Views Matter?

Rediff.com5 Dec 2023

About 21 per cent Indians born between the mid-1990s and mid-2010s say a potential partner not aligning politically with them is a dating red flag.

India home to 18 of 20 cities with most severe rise in PM2.5 pollution: Report

India home to 18 of 20 cities with most severe rise in PM2.5 pollution: Report

Rediff.com17 Aug 2022

The report Air Quality and Health in Cities combined ground-based air quality data with satellites and models to produce air quality estimates for cities around the world.

Shafali Jeste leads way in understanding autism

Shafali Jeste leads way in understanding autism

Rediff.com22 Jun 2010

Dr Shafali Jeste is one of the many young, talented and unsung heroes in the Indian-American community. She was recently featured in Science magazine for her cutting-edge research in translating the puzzle of autism into treatment.

'This is definitely not an act done by a sane person'

'This is definitely not an act done by a sane person'

Rediff.com15 Jan 2024

'I feel she has some mental disorder. Or, it was an act of pure revenge.'

Modi's 2-day K'taka visit from Monday, to attend Yoga Day event in Mysore

Modi's 2-day K'taka visit from Monday, to attend Yoga Day event in Mysore

Rediff.com19 Jun 2022

The PMO said mass yoga demonstrations will be organised at 75 iconic locations across the country under the leadership of 75 Union ministers, with Modi attending the exercise at Mysore.

Sitharaman lists climate finance, crypto regulation as key G20 agenda

Sitharaman lists climate finance, crypto regulation as key G20 agenda

Rediff.com2 Nov 2022

Climate and sustainable development financing, multilateral institution reforms, regulation of digital assets, the spillover effect on developing economies from actions of western central banks, energy and food security in the backdrop of war in Europe, and sanctions on Russia and their impact on the global economy are some of the agenda items that India will take up as President of G-20, Finance Minister Nirmala Sitharaman said on Tuesday. India will take over as President of the powerful international grouping on December 1 for a year. There will be around 200 meetings throughout the country, with the summit Heads of State meeting expected to be held in New Delhi next September.

Covid likely came from lab leak in China: Report

Covid likely came from lab leak in China: Report

Rediff.com27 Feb 2023

The new report highlights how different parts of the intelligence community have arrived at disparate judgments about the pandemic's origin.

Moderna says its COVID-19 vaccine is 94.5% effective

Moderna says its COVID-19 vaccine is 94.5% effective

Rediff.com16 Nov 2020

Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.

Covaxin maker to pay compensation in case of side effects

Covaxin maker to pay compensation in case of side effects

Rediff.com16 Jan 2021

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.

Soumya Swaminathan: Just what the doctor ordered

Soumya Swaminathan: Just what the doctor ordered

Rediff.com14 Oct 2017

Her appointment as World Health Organisation's deputy director offers an opportunity to push for improving the medical research environment in India.

How IITs are gearing up to fight COVID-19 menace

How IITs are gearing up to fight COVID-19 menace

Rediff.com31 Mar 2020

While some researchers are developing prototypes for ventilators to overcome their shortage, others have teamed up to develop testing kits.

Rapid antigen tests are spuriously comforting: Scientists

Rapid antigen tests are spuriously comforting: Scientists

Rediff.com11 Sep 2020

'There are not enough RT-PCR tests and they take a long time to do in specialised centres. So the world is using RA tests for the same reason that India is using them, and with similar somewhat spuriously comforting rationale'

Why Govt Wants To Ban These Cough Meds

Why Govt Wants To Ban These Cough Meds

Rediff.com17 Oct 2022

Codeine-based formulations are under the scanner for misuse as a narcotic product.

Varanasi to London: Tiranga Pix

Varanasi to London: Tiranga Pix

Rediff.com15 Aug 2022

Readers tell us how they are celebrating the

India's first COVID-19 vaccine gets nod for human trials

India's first COVID-19 vaccine gets nod for human trials

Rediff.com30 Jun 2020

COVAXIN, developed by Hyderabad-based Bharat Biotech in collaboration with Indian Council of Medical Research and National Institute of Virology, has got the nod for human clinical trials from the Drug Controller General of India

Obama appoints Indian American to national science board

Obama appoints Indian American to national science board

Rediff.com4 Jul 2014

Dr Sethuraman 'Panch' Panchanathan, senior vice president, Office of Knowledge Enterprise Development, ArizonaStateUniversity, was last week appointed to the United States National Science Board by President Barack Obama.

More than skin-deep: Nifty Next 50 complexion to get a shade of difference

More than skin-deep: Nifty Next 50 complexion to get a shade of difference

Rediff.com12 Jun 2023

The National Stock Exchange (NSE) Nifty Next 50 Index could undergo large-scale changes if the proposed tweaks to its computation methodology get implemented. In a discussion paper floated recently, NSE Indices, which owns and manages a portfolio of over 350 indices under the Nifty brand, proposed that only stocks that are traded in the futures and options (F&O) segment can be part of the index. Currently, as many as 11 non-F&O stocks are part of the Nifty Next 50 Index, which, as the name suggests, represents the next rung of large and liquid securities after the Nifty50.

DRDO gets govt nod to work on biological defence

DRDO gets govt nod to work on biological defence

Rediff.com12 May 2020

While it was not directly suggested that the COVID-19 pandemic was related to biological warfare, it is significant that the government is exhorting military laboratories to work concertedly on biological defence.

BRICS has adopted a counter-terrorism plan: Modi

BRICS has adopted a counter-terrorism plan: Modi

Rediff.com9 Sep 2021

Asserting that it is for the first time that BRICS has taken a collective position on strengthening and reforming multilateral systems, Prime Minister Narendra Modi said, "We have to ensure that BRICS is more productive in the next 15 years".

'Will have to go aggressive; can still suspend public transport'

'Will have to go aggressive; can still suspend public transport'

Rediff.com18 Mar 2020

Maharashtra Health Minister Rajesh Tope warns that the state government will go aggressive if appeals to reduce social distancing are not adhered to.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

Is A Vaccine Booster Needed?

Is A Vaccine Booster Needed?

Rediff.com20 Dec 2021

'There is no emergency of a third wave that we are rushing for booster doses.'

Reliance proposes using tapeworm drug to treat Covid patients

Reliance proposes using tapeworm drug to treat Covid patients

Rediff.com3 Jun 2021

Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Covaxin found to neutralise 617 Covid variant: Dr Fauci

Rediff.com28 Apr 2021

The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.

Yoginder Alagh's Death Is A Loss To India

Yoginder Alagh's Death Is A Loss To India

Rediff.com7 Dec 2022

For Yoginder, it is a release from pain. But for us, his friends, it is the loss of a warm and generous life companion, says Nitin Desai of his 50-year association with the eminent economist who passed into the ages on December 6, 2022.